https://www.selleckchem.com/pr....oducts/iodoacetamide
Serum metabolome is a promising source of molecular biomarkers that could support early detection of lung cancer in screening programs based on low-dose computed tomography. Several panels of metabolites that differentiate lung cancer patients and healthy individuals were reported, yet none of them were validated in the population at high-risk of developing cancer. Here we analyzed serum metabolome profiles in participants of two lung cancer screening studies MOLTEST-BIS (Poland, n = 369) and SMAC-1 (Italy, n = 93). Three groups o